{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:20:28Z","timestamp":1740122428962,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA131332, CA175080"],"award-info":[{"award-number":["CA131332, CA175080"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 CA186107 and P01 CA087969"],"award-info":[{"award-number":["UM1 CA186107 and P01 CA087969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01 CA176726"],"award-info":[{"award-number":["U01 CA176726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000142","name":"Avon Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen for the Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10552-020-01321-0","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T12:02:33Z","timestamp":1590926553000},"page":"827-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-5340","authenticated-orcid":false,"given":"Lusine","family":"Yaghjyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemi","family":"Wijayabahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,31]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","volume":"6","author":"NF Boyd","year":"2005","unstructured":"Boyd NF, Rommens JM, Vogt K et al (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798\u2013808","journal-title":"Lancet Oncol"},{"key":"1321_CR2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6604635","volume":"99","author":"OM Ginsburg","year":"2008","unstructured":"Ginsburg OM, Martin LJ, Boyd NF (2008) Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 99:1369\u20131374","journal-title":"Br J Cancer"},{"key":"1321_CR3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jnci\/djm062","volume":"99","author":"RM Tamimi","year":"2007","unstructured":"Tamimi RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178\u20131187","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiol.2301020870","volume":"230","author":"JA Harvey","year":"2004","unstructured":"Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230:29\u201341","journal-title":"Radiology"},{"key":"1321_CR5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF, Byng JW, Jong RA et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670\u2013675","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR6","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/jnci\/87.21.1622","volume":"87","author":"C Byrne","year":"1995","unstructured":"Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622\u20131629","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR7","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/bcr3041","volume":"13","author":"A Pettersson","year":"2011","unstructured":"Pettersson A, Hankinson S, Willett W, Lagiou P, Trichopoulos D, Tamimi R (2011) Nondense mammographic area and risk of breast cancer. Breast Cancer Res 13:R100","journal-title":"Breast Cancer Res"},{"key":"1321_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1055-9965.EPI-09-1059","volume":"19","author":"Z Aitken","year":"2010","unstructured":"Aitken Z, McCormack VA, Highnam RP et al (2010) Screen-film mammographic density and breast cancer risk: a comparison of the volumetric standard mammogram form and the interactive threshold measurement methods. Cancer Epidemiol Biomark Prev 19:418\u2013428","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1321_CR9","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/bcr2778","volume":"12","author":"J Stone","year":"2010","unstructured":"Stone J, Ding J, Warren RM, Duffy SW, Hopper JL (2010) Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 12:R97","journal-title":"Breast Cancer Res"},{"key":"1321_CR10","first-page":"332","volume":"12","author":"G Ursin","year":"2003","unstructured":"Ursin G, Ma H, Wu AH et al (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12:332\u2013338","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1321_CR11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/aje\/kwi270","volume":"162","author":"G Maskarinec","year":"2005","unstructured":"Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN (2005) Mammographic density and breast cancer risk. Am J Epidemiol 162:743\u2013752","journal-title":"Am J Epidemiol"},{"key":"1321_CR12","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1158\/1055-9965.EPI-09-0107","volume":"18","author":"N Boyd","year":"2009","unstructured":"Boyd N, Martin L, Gunasekara A et al (2009) Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomark Prev 18:1754\u20131762","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1321_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1055-9965.EPI-06-0738","volume":"16","author":"CM Vachon","year":"2007","unstructured":"Vachon CM, Brandt KR, Ghosh K et al (2007) Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomark Prev 16:43\u201349","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1321_CR14","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/bcr3044","volume":"13","author":"M Lokate","year":"2011","unstructured":"Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH (2011) Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res 13:R103","journal-title":"Breast Cancer Res"},{"key":"1321_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju078","author":"A Pettersson","year":"2014","unstructured":"Pettersson A, Graff RE, Ursin G et al (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju078","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","volume":"126","author":"A Bardia","year":"2011","unstructured":"Bardia A, Olson JE, Vachon CM et al (2011) Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 126:149\u2013155","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10552-011-9832-6","volume":"22","author":"JL Bosco","year":"2011","unstructured":"Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L (2011) Regular aspirin use and breast cancer risk in US Black women. Cancer Causes Control 22:1553\u20131561","journal-title":"Cancer Causes Control"},{"key":"1321_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","volume":"111","author":"DM Fraser","year":"2014","unstructured":"Fraser DM, Sullivan FM, Thompson AM, McCowan C (2014) Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer 111:623\u2013627","journal-title":"Br J Cancer"},{"key":"1321_CR19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-015-1979-1","volume":"15","author":"S Kim","year":"2015","unstructured":"Kim S, Shore DL, Wilson LE et al (2015) Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer. BMC Cancer 15:960","journal-title":"BMC Cancer"},{"key":"1321_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mayocp.2015.10.018","volume":"91","author":"A Bardia","year":"2016","unstructured":"Bardia A, Keenan TE, Ebbert JO et al (2016) Personalizing aspirin use for targeted breast cancer chemoprevention in postmenopausal women. Mayo Clin Proc 91:71\u201380","journal-title":"Mayo Clin Proc"},{"key":"1321_CR21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/cncr.30004","volume":"122","author":"MC Bradley","year":"2016","unstructured":"Bradley MC, Black A, Freedman AN, Barron TI (2016) Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: a cohort study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 122:2067\u20132075","journal-title":"Cancer"},{"key":"1321_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13058-017-0840-7","volume":"19","author":"CA Clarke","year":"2017","unstructured":"Clarke CA, Canchola AJ, Moy LM et al (2017) Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study. Breast Cancer Res 19:52","journal-title":"Breast Cancer Res"},{"key":"1321_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294:47\u201355","journal-title":"JAMA"},{"key":"1321_CR24","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.2012.42.2006","volume":"30","author":"X Zhang","year":"2012","unstructured":"Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE (2012) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 30:3468\u20133477","journal-title":"J Clin Oncol"},{"key":"1321_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-14-391","volume":"14","author":"MD Holmes","year":"2014","unstructured":"Holmes MD, Olsson H, Pawitan Y et al (2014) Aspirin intake and breast cancer survival: a nation-wide study using prospectively recorded data in Sweden. BMC Cancer 14:391","journal-title":"BMC Cancer"},{"key":"1321_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/archinternmed.2008.537","volume":"169","author":"AH Eliassen","year":"2009","unstructured":"Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE (2009) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med 169:115\u2013121","journal-title":"Arch Intern Med"},{"key":"1321_CR27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jnci\/djn324","volume":"100","author":"B Takkouche","year":"2008","unstructured":"Takkouche B, Regueira-Mendez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100:1439\u20131447","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/1055-9965.EPI-08-1088","volume":"18","author":"A McTiernan","year":"2009","unstructured":"McTiernan A, Wang CY, Sorensen B et al (2009) No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Prev 18:1524\u20131530","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1321_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10549-011-1834-2","volume":"132","author":"J Stone","year":"2012","unstructured":"Stone J, Willenberg L, Apicella C, Treloar S, Hopper J (2012) The association between mammographic density measures and aspirin or other NSAID use. Breast Cancer Res Treat 132:259\u2013266","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-017-4127-6","volume":"162","author":"ME Wood","year":"2017","unstructured":"Wood ME, Sprague BL, Oustimov A et al (2017) Aspirin use is associated with lower mammographic density in a large screening cohort. Breast Cancer Res Treat 162:419\u2013425","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR31","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/1055-9965.EPI-08-1088","volume":"18","author":"A McTiernan","year":"2009","unstructured":"McTiernan A, Wang CY, Sorensen B et al (2009) No effect of aspirin on mammographic density in a randomized controlled clinical trial. Cancer Epidemiol Biomarkers Preven 18:1524\u20131530","journal-title":"Cancer Epidemiol Biomarkers Preven"},{"key":"1321_CR32","doi-asserted-by":"crossref","first-page":"e1229723","DOI":"10.1080\/2162402X.2016.1229723","volume":"5","author":"A Abrahamsson","year":"2016","unstructured":"Abrahamsson A, Rzepecka A, Romu T et al (2016) Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivo. Oncoimmunology 5:e1229723","journal-title":"Oncoimmunology"},{"key":"1321_CR33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE (2005) The nurses' health study: lifestyle and health among women. Nat Rev Cancer 5:388\u2013396","journal-title":"Nat Rev Cancer"},{"key":"1321_CR34","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66:2476\u20132482","journal-title":"Cancer Res"},{"key":"1321_CR35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-014-3247-5","volume":"149","author":"KA Bertrand","year":"2015","unstructured":"Bertrand KA, Rosner B, Eliassen AH et al (2015) Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat 149:479\u2013487","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00008469-199610000-00003","volume":"5","author":"JW Byng","year":"1996","unstructured":"Byng JW, Boyd NF, Little L et al (1996) Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev 5:319\u2013327","journal-title":"Eur J Cancer Prev"},{"key":"1321_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-012-2240-0","volume":"136","author":"K Bertrand","year":"2012","unstructured":"Bertrand K, Eliassen AH, Hankinson S et al (2012) Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat 136:277\u2013287","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10552-017-0898-7","volume":"28","author":"MS Rice","year":"2017","unstructured":"Rice MS, Rosner BA, Tamimi RM (2017) Percent mammographic density prediction: development of a model in the nurses' health studies. Cancer Causes Control 28:677\u2013684","journal-title":"Cancer Causes Control"},{"key":"1321_CR39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a113598","volume":"117","author":"W Willett","year":"1983","unstructured":"Willett W, Stampfer MJ, Bain C et al (1983) Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117:651\u2013658","journal-title":"Am J Epidemiol"},{"key":"1321_CR40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","volume":"313","author":"MJ Stampfer","year":"1985","unstructured":"Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044\u20131049","journal-title":"N Engl J Med"},{"key":"1321_CR41","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjc.2015.315","volume":"113","author":"L Yaghjyan","year":"2015","unstructured":"Yaghjyan L, Pettersson A, Colditz GA et al (2015) Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers. Br J Cancer 113:1104\u20131113","journal-title":"Br J Cancer"},{"key":"1321_CR42","first-page":"728","volume":"12","author":"J Brisson","year":"2003","unstructured":"Brisson J, Diorio C, M\u00e2sse B (2003) Wolfe\u2019s parenchymal pattern and percentage of the breast with mammographic densities. Redund Complement Classific 12:728\u2013732","journal-title":"Redund Complement Classific"},{"key":"1321_CR43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-015-3286-6","volume":"150","author":"L Yaghjyan","year":"2015","unstructured":"Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2015) Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. Breast Cancer Res Treat 150:181\u2013189","journal-title":"Breast Cancer Res Treat"},{"key":"1321_CR44","doi-asserted-by":"crossref","first-page":"942386","DOI":"10.1155\/2014\/942386","volume":"2014","author":"V Lienart","year":"2014","unstructured":"Lienart V, Carly B, Kang X, Guzy L, Sajovitz A-M, Liebens F (2014) Effect of preventive hormonal therapy on breast density: a systematic qualitative review. Sci World J 2014:942386","journal-title":"Sci World J"},{"key":"1321_CR45","first-page":"151","volume":"9","author":"CM Vachon","year":"2000","unstructured":"Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the minnesota breast cancer family cohort. Cancer Epidemiol Biomark Prev 9:151\u2013160","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1321_CR46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/aje\/kwr225","volume":"174","author":"HR Harris","year":"2011","unstructured":"Harris HR, Tamimi RM, Willett WC, Hankinson SE, Michels KB (2011) Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol 174:909\u2013918","journal-title":"Am J Epidemiol"},{"key":"1321_CR47","first-page":"126","volume":"61","author":"I Czajka-Oraniec","year":"2010","unstructured":"Czajka-Oraniec I, Simpson ER (2010) Aromatase research and its clinical significance. Endokrynol Pol 61:126\u2013134","journal-title":"Endokrynol Pol"},{"key":"1321_CR48","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jnci\/djr225","volume":"103","author":"L Yaghjyan","year":"2011","unstructured":"Yaghjyan L, Colditz GA, Collins LC et al (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103:1179\u20131189","journal-title":"J Natl Cancer Inst"},{"key":"1321_CR49","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1055-9965.EPI-13-0169","volume":"22","author":"L Yaghjyan","year":"2013","unstructured":"Yaghjyan L, Colditz GA, Rosner B, Tamimi RM (2013) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomarkers Prev 22:1110\u20131117","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01321-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-020-01321-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01321-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T23:32:16Z","timestamp":1622417536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-020-01321-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s10552-020-01321-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the institutional review boards of the Brigham and Women\u2019s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required. Consent was obtained or implied by return of questionnaires.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}